To evaluate the effect of treatment of insulin resistance in the response of chronic
hepatitis C treatment, mesure as HCV-RNA negative at week 72.
4.3.2 Objetivos secundarios To evaluate the efficacy and safety of treatment with metformine
to erradicate the insulin resistance of patients with chornic hepatitis C genotype 1 measure
as HOMA-IR < 2.